Can virus infections trigger autoimmune disease?

Journal of Autoimmunity

Volumn 16, Issue 3, 2001, Pages 229-234

  Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HUMAN; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0034983697     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0484     Document Type: Conference Paper

References (63)

1. The epidemiology of multiple sclerosis
2. Multiple sclerosis. History, definition and general considerations
3. Multiple sclerosis
4. A population-based study of multiple sclerosis in twins
5. A population-based study of multiple sclerosis in twins: Update
6. The British Isles survey of multiple sclerosis in twins
7. The genetics of multiple sclerosis. A review
8. Genetics of multiple sclerosis - How could disease-associated HLA-types contribute to pathogenesis?
9. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation
10. The dissemination of multiple sclerosis: A Viking saga? A historical essay
11. Epidemiologic evidence for multiple sclerosis as an infection
12. Risk of multiple sclerosis related to age at immigration to Israel
13. A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance
14. Mortality and migration in multiple sclerosis
15. On the risk of multiple sclerosis according to age at immigration to South Africa
16. Migration and risk of multiple sclerosis
17. When is multiple sclerosis acquired?
18. Early environmental events as a cause of IDDM. Evidence and implications
19. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic
20. Observations on the prevalence of multiple sclerosis in Northern Scotland
21. Some neurological aspects of medical geography
22. Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland
23. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology
24. Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission
25. Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics
26. Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of MS
27. Role of bacterial infection in exacerbation of multiple sclerosis
28. Urinary tract infections may trigger relapse in multiple sclerosis
29. Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study
30. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis
31. Influence of infection on exacerbations of multiple sclerosis
32. Clinical viral infections and multiple sclerosis
33. Chronic inflammatory and demyelinating diseases
34. High frequency of diabetes mellitus in young adults with congenital rubella
35. Congenital rubella and diabetes mellitus
36. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome
37. s mouse strains
38. Influenza vaccination in patients with multiple sclerosis
39. Swine influenza virus vaccination in patients with multiple sclerosis
40. Lack of association of Swine flu vaccine and rheumatoid arthritis
41. Swine influenza vaccination in patients with multiple sclerosis
42. Reassessment of the association between Guillain-Barre syndrome and receipt of swine influenza vaccine in 1976-1977: Results of a two-state study
43. Influenza virus vaccination of patients with multiple sclerosis
44. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
45. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
46. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
47. Vaccination and autoimmunity-'vaccinosis': A dangerous liaison?
48. School-based hepatitis B vaccination programme and adolescent multiple sclerosis
49. Is there a causal link between hepatitis B vaccination and multiple sclerosis?
50. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein
51. Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis
52. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis
53. Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein
54. Two models for multiple sclerosis: Experimental allergic encephalomyelitis Theiler's murine encephalomyelitis virus
55. Myoblasts fail to stimulate T cells but induce tolerance
56. 1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
57. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T cell costimulation
58. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis
59. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen
60. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
61. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo
62. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis